Clinical Trial Update: Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer [Phase 3]

View source ↗

Summary

BioNTech's investigational therapy BNT327, in combination with chemotherapy, is being studied in untreated extensive-stage small-cell lung cancer in Phase 3 and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• BNT327

Snippet

Sponsor: BioNTech SE | Conditions: Extensive-stage Small-cell Lung Cancer | Phase 3 | Status: RECRUITING